# CTSN Embolic Protection Trial

> **NCT06027788** · NA · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 842 (estimated)

## Conditions studied

- Delirium
- Ischemic Stroke
- Acute Kidney Injury
- Heart Valve Disease
- Coronary Artery Disease

## Interventions

- **DEVICE:** CardioGard Embolic Protection Cannula
- **DEVICE:** Standard Aortic Cannula

## Key facts

- **NCT ID:** NCT06027788
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-18
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 842 (ESTIMATED)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06027788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06027788, "CTSN Embolic Protection Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06027788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*